COVID-19 – Page 6 – Bizzell US

2Dec2020

Coping with Holiday Blues During COVID-19

In a Psychology Today article, “Coping With Holiday Blues During COVID-19,” Dr. Anton C. Bizzell focuses on how to cope with holiday blues during COVID-19, including tips for recognizing and managing your stressors.

The holiday season is a wonderful opportunity to spend time with family and friends, catch up, participate in family and religious traditions, and enjoy the company of loved ones. For some, the holidays are associated with triggers, stressors, and emotional landmines. For many of us, it is both. And all of us will have to alter our holiday routines due to the virus. However, we can navigate the holiday season by using simple but powerful tools. Doing so allows us to enjoy the benefits that the holiday season can bring and take steps to prevent or manage stress. We can create a new holiday normal, Dr. Bizzell concludes.

5Nov2020

Preserving the Mental Wellness of Our Healthcare Heroes

Dr. Anton C. Bizzell underscores in Psychology Today how The Bizzell Group (Bizzell) helps preserve the mental wellness of our healthcare heroes. People often choose a career in medicine because they desire to help, heal, and make a difference. They have the drive to fulfill these responsibilities, and their accomplishments are often groundbreaking. “We can never forget that these healthcare workers are human beings, not robots,” Dr. Bizzell writes. “As this pandemic stretches toward a second year, we cannot expect them to continue to do their jobs well without better support for their mental well-being.” Organizations—including Bizzell—are beginning to step up at the national, state, and local levels to help these everyday heroes.

4Nov2020

Addressing the Signs of Mental Health Decline in the Workplace

In a recent U.S. Chamber of Commerce Foundation (USCCF) blog post, “How Forward-Looking Companies Can Address the Signs of Mental Health Decline in the Workplace,” Dr. Anton C. Bizzell discusses how business leaders can learn the signs of mental health disorders in the workplace and shares strategies employers can implement to boost company morale. As a small business owner and advisory board member for the U.S. Chamber of Commerce Foundation, Dr. Bizzell has witnessed first-hand how negative repercussions due to an unfavorable environment could impact employees’ mental health.
The initial step for any business owner looking to address mental health in their workplace is to learn the signs of decline in mental health before it has a much larger domino effect. If an employee’s mental health is altered due to discouragement at work, there are strategies employers can implement to help manage mental health decline and boost company morale, Dr. Bizzell writes.

16Oct2020

Dr. Bizzell Speaks About the First FDA-Approved Treatment for Ebola

Dr. Anton C. Bizzell shares his insights in the Verywell Health article, “Regeneron Earns First-Ever FDA Approval For Ebola Treatment,” about the U.S. Food and Drug Administration (FDA) approval of Inmazeb, an antibody cocktail designed to treat the Ebola virus. A mixture of three monoclonal antibodies administered via injection is the first FDA-approved treatment for the virus. The drug is manufactured by Regeneron, the same company behind the antibody cocktail aimed at treating COVID-19. The Bizzell Group (Bizzell) has been on the ground fighting the Ebola virus in the Democratic Republic of Congo. “The approval of Inmazeb is not only a big deal, it is the approach to prevent a future Ebola pandemic worldwide,” Dr. Bizzell tells Verywell.

Previous page 1 … 4 5 6 7 8 9 Next page

Tag Archives: COVID-19

Coping with Holiday Blues During COVID-19

Coping with Holiday Blues During COVID-19

Preserving the Mental Wellness of Our Healthcare Heroes

Preserving the Mental Wellness of Our Healthcare Heroes

Addressing the Signs of Mental Health Decline in the Workplace

Addressing the Signs of Mental Health Decline in the Workplace

Dr. Bizzell Speaks About the First FDA-Approved Treatment for Ebola

Dr. Bizzell Speaks About the First FDA-Approved Treatment for Ebola

Contact Us